1-18 of 18
Gabriella Fontanini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Crizotinib in ROS1 and MET Deregulated NSCLC—Response

Lorenza Landi, Rossella Bruno, Gabriella Fontanini, Federico Cappuzzo
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1775.
https://doi.org/10.1158/1078-0432.CCR-20-0026
Published: 01 April 2020
View article titled, Crizotinib in <em>ROS1</em> and <em>MET</em> Deregulated NSCLC—Response
Open the PDF for Crizotinib in <em>ROS1</em> and <em>MET</em> Deregulated NSCLC—Response in another window
Journal Articles

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo, Federica D'Incà, Claudio Dazzi, Antonio Chella, Angelo Delmonte, Laura Bonanno, Diana Giannarelli, Diego Luigi Cortinovis, Filippo de Marinis, Gloria Borra, Alessandro Morabito, Cesare Gridelli, Domenico Galetta, Fausto Barbieri, Francesco Grossi, Enrica Capelletto, Gabriele Minuti, Francesca Mazzoni, Claudio Verusio, Emilio Bria, Greta Alì, Rossella Bruno, Agnese Proietti, Gabriella Fontanini, Lucio Crinò, Federico Cappuzzo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (24): 7312–7319.
https://doi.org/10.1158/1078-0432.CCR-19-0994
Published: 13 December 2019
View article titled, Crizotinib in <em>MET</em>-Deregulated or <em>ROS1</em>-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial
Open the PDF for Crizotinib in <em>MET</em>-Deregulated or <em>ROS1</em>-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial in another window
Includes: Supplementary data
Journal Articles

Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization

Marta Schirripa, Paola Biason, Sara Lonardi, Nicoletta Pella, Maria Simona Pino, Federica Urbano, Carlotta Antoniotti, Chiara Cremolini, Salvatore Corallo, Filippo Pietrantonio, Fabio Gelsomino, Stefano Cascinu, Armando Orlandi, Giada Munari, Umberto Malapelle, Serena Saggio, Gabriella Fontanini, Massimo Rugge, Claudia Mescoli, Stefano Lazzi, Luca Reggiani Bonetti, Giovanni Lanza, Angelo Paolo Dei Tos, Giovanna De Maglio, Maurizio Martini, Francesca Bergamo, Vittorina Zagonel, Fotios Loupakis, Matteo Fassan
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 3954–3961.
https://doi.org/10.1158/1078-0432.CCR-19-0311
Published: 01 July 2019
View article titled, Class 1, 2, and 3 <em>BRAF</em>-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization
Open the PDF for Class 1, 2, and 3 <em>BRAF</em>-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization in another window
Includes: Supplementary data
Journal Articles

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients

Carmine Carbone, Geny Piro, Francesca Simionato, Francesca Ligorio, Chiara Cremolini, Fotios Loupakis, Greta Alì, Daniele Rossini, Valeria Merz, Raffaela Santoro, Camilla Zecchetto, Marco Zanotto, Federica Di Nicolantonio, Alberto Bardelli, Gabriella Fontanini, Giampaolo Tortora, Davide Melisi
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4312–4322.
https://doi.org/10.1158/1078-0432.CCR-16-3153
Published: 01 August 2017
View article titled, Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients
Open the PDF for Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients in another window
Includes: Supplementary data
Journal Articles

WWOX Expression in Different Histologic Types and Subtypes of Non–Small Cell Lung Cancer

Valentina Donati, Gabriella Fontanini, Matteo Dell'Omodarme, Maria Cristina Prati, Simona Nuti, Marco Lucchi, Alfredo Mussi, Muller Fabbri, Fulvio Basolo, Carlo Maria Croce, Rami Ishaq Aqeilan
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (3): 884–891.
https://doi.org/10.1158/1078-0432.CCR-06-2016
Published: 08 February 2007
View article titled, WWOX Expression in Different Histologic Types and Subtypes of Non–Small Cell Lung Cancer
Open the PDF for WWOX Expression in Different Histologic Types and Subtypes of Non–Small Cell Lung Cancer in another window
Journal Articles

Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung Cancer

Valentina Donati, Laura Boldrini, Matteo Dell'Omodarme, Maria C. Prati, Pinuccia Faviana, Tiziano Camacci, Marco Lucchi, Alfredo Mussi, Massimo Santoro, Fulvio Basolo, Gabriella Fontanini
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6459–6465.
https://doi.org/10.1158/1078-0432.CCR-05-0541
Published: 15 September 2005
View article titled, Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung Cancer
Open the PDF for Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung Cancer in another window
Journal Articles

Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma

Vincenzo Damiano, Davide Melisi, Cataldo Bianco, David Raben, Rosa Caputo, Gabriella Fontanini, Roberto Bianco, Anderson Ryan, A. Raffaele Bianco, Sabino De Placido, Fortunato Ciardiello, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5639–5644.
https://doi.org/10.1158/1078-0432.CCR-05-0174
Published: 01 August 2005
View article titled, Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma
Open the PDF for Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma in another window
Journal Articles

Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor-2 and Epidermal Growth Factor Receptor Small Molecule Tyrosine Kinase Inhibitor, in Combination with SC-236, a Cyclooxygenase-2 Inhibitor

Concetta Tuccillo, Marco Romano, Teresa Troiani, Erika Martinelli, Floriana Morgillo, Ferdinando De Vita, Roberto Bianco, Gabriella Fontanini, Raffaele A. Bianco, Giampaolo Tortora, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1268–1276.
https://doi.org/10.1158/1078-0432.1268.11.3
Published: 11 February 2005
View article titled, Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor-2 and Epidermal Growth Factor Receptor Small Molecule Tyrosine Kinase Inhibitor, in Combination with SC-236, a Cyclooxygenase-2 Inhibitor
Open the PDF for Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor-2 and Epidermal Growth Factor Receptor Small Molecule Tyrosine Kinase Inhibitor, in Combination with SC-236, a Cyclooxygenase-2 Inhibitor in another window
Journal Articles

Expression and Mutational Status of c-kit in Small-Cell Lung Cancer: Prognostic Relevance

Laura Boldrini, Silvia Ursino, Silvia Gisfredi, Pinuccia Faviana, Valentina Donati, Tiziano Camacci, Marco Lucchi, Alfredo Mussi, Fulvio Basolo, Raffaele Pingitore, Gabriella Fontanini
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4101–4108.
https://doi.org/10.1158/1078-0432.CCR-03-0664
Published: 24 June 2004
View article titled, Expression and Mutational Status of <em>c-kit</em> in Small-Cell Lung Cancer: <subtitle>Prognostic Relevance</subtitle>
Open the PDF for Expression and Mutational Status of <em>c-kit</em> in Small-Cell Lung Cancer: <subtitle>Prognostic Relevance</subtitle> in another window
Journal Articles

Combination of a Selective Cyclooxygenase-2 Inhibitor with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 and Protein Kinase A Antisense Causes Cooperative Antitumor and Antiangiogenic Effect

Giampaolo Tortora, Rosa Caputo, Vincenzo Damiano, Davide Melisi, Roberto Bianco, Gabriella Fontanini, Bianca Maria Veneziani, Sabino De Placido, A. Raffaele Bianco, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1566–1572.
Published: 01 April 2003
View article titled, Combination of a Selective Cyclooxygenase-2 Inhibitor with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 and Protein Kinase A Antisense Causes Cooperative Antitumor and Antiangiogenic Effect
Open the PDF for Combination of a Selective Cyclooxygenase-2 Inhibitor with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 and Protein Kinase A Antisense Causes Cooperative Antitumor and Antiangiogenic Effect in another window
Journal Articles

Antitumor Effects of ZD6474, a Small Molecule Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, with Additional Activity against Epidermal Growth Factor Receptor Tyrosine Kinase

Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano, Roberta Caputo, Teresa Troiani, Donatella Vitagliano, Francesca Carlomagno, Bianca Maria Veneziani, Gabriella Fontanini, A. Raffaele Bianco, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1546–1556.
Published: 01 April 2003
View article titled, Antitumor Effects of ZD6474, a Small Molecule Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, with Additional Activity against Epidermal Growth Factor Receptor Tyrosine Kinase
Open the PDF for Antitumor Effects of ZD6474, a Small Molecule Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, with Additional Activity against Epidermal Growth Factor Receptor Tyrosine Kinase in another window
Journal Articles

Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Cataldo Bianco, Giampaolo Tortora, Roberto Bianco, Roberta Caputo, Bianca Maria Veneziani, Rosa Caputo, Vincenzo Damiano, Teresa Troiani, Gabriella Fontanini, David Raben, Stefano Pepe, A. Raffaele Bianco, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3250–3258.
Published: 01 October 2002
View article titled, Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa)
Open the PDF for Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa) in another window
Journal Articles

Oral Administration of a Novel Taxane, an Antisense Oligonucleotide Targeting Protein Kinase A, and the Epidermal Growth Factor Receptor Inhibitor Iressa Causes Cooperative Antitumor and Antiangiogenic Activity

Giampaolo Tortora, Rosa Caputo, Vincenzo Damiano, Gabriella Fontanini, Davide Melisi, Bianca Maria Veneziani, Franco Zunino, A. Raffaele Bianco, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (12): 4156–4163.
Published: 01 December 2001
View article titled, Oral Administration of a Novel Taxane, an Antisense Oligonucleotide Targeting Protein Kinase A, and the Epidermal Growth Factor Receptor Inhibitor Iressa Causes Cooperative Antitumor and Antiangiogenic Activity
Open the PDF for Oral Administration of a Novel Taxane, an Antisense Oligonucleotide Targeting Protein Kinase A, and the Epidermal Growth Factor Receptor Inhibitor Iressa Causes Cooperative Antitumor and Antiangiogenic Activity in another window
Journal Articles

Combined Blockade of Protein Kinase A and Bcl-2 by Antisense Strategy Induces Apoptosis and Inhibits Tumor Growth and Angiogenesis

Giampaolo Tortora, Rosa Caputo, Vincenzo Damiano, Roberto Bianco, Gabriella Fontanini, Sabina Cuccato, Sabino De Placido, A. Raffaele Bianco, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2537–2544.
Published: 01 August 2001
View article titled, Combined Blockade of Protein Kinase A and Bcl-2 by Antisense Strategy Induces Apoptosis and Inhibits Tumor Growth and Angiogenesis
Open the PDF for Combined Blockade of Protein Kinase A and Bcl-2 by Antisense Strategy Induces Apoptosis and Inhibits Tumor Growth and Angiogenesis in another window
Journal Articles

Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Fortunato Ciardiello, Rosa Caputo, Roberto Bianco, Vincenzo Damiano, Gabriella Fontanini, Sabina Cuccato, Sabino De Placido, A. Raffaele Bianco, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1459–1465.
Published: 01 May 2001
View article titled, Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Open the PDF for Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in another window
Journal Articles

Antiangiogenic and Antitumor Activity of Anti-Epidermal Growth Factor Receptor C225 Monoclonal Antibody in Combination with Vascular Endothelial Growth Factor Antisense Oligonucleotide in Human GEO Colon Cancer Cells

Fortunato Ciardiello, Roberto Bianco, Vincenzo Damiano, Gabriella Fontanini, Rosa Caputo, Grazia Pomatico, Sabino De Placido, A. Raffaele Bianco, John Mendelsohn, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (9): 3739–3747.
Published: 01 September 2000
View article titled, Antiangiogenic and Antitumor Activity of Anti-Epidermal Growth Factor Receptor C225 Monoclonal Antibody in Combination with Vascular Endothelial Growth Factor Antisense Oligonucleotide in Human GEO Colon Cancer Cells
Open the PDF for Antiangiogenic and Antitumor Activity of Anti-Epidermal Growth Factor Receptor C225 Monoclonal Antibody in Combination with Vascular Endothelial Growth Factor Antisense Oligonucleotide in Human GEO Colon Cancer Cells in another window
Journal Articles

Oral Antisense that Targets Protein Kinase A Cooperates with Taxol and Inhibits Tumor Growth, Angiogenesis, and Growth Factor Production

Giampaolo Tortora, Roberto Bianco, Vincenzo Damiano, Gabriella Fontanini, Sabino De Placido, A. Raffaele Bianco, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2506–2512.
Published: 01 June 2000
View article titled, Oral Antisense that Targets Protein Kinase A Cooperates with Taxol and Inhibits Tumor Growth, Angiogenesis, and Growth Factor Production
Open the PDF for Oral Antisense that Targets Protein Kinase A Cooperates with Taxol and Inhibits Tumor Growth, Angiogenesis, and Growth Factor Production in another window
Journal Articles

Thrombospondins I and II Messenger RNA Expression in Lung Carcinoma: Relationship with p53 Alterations, Angiogenic Growth Factors, and Vascular Density

Gabriella Fontanini, Laura Boldrini, Alessandra Calcinai, Silvana Chinè, Marco Lucchi, Alfredo Mussi, Carlo Alberto Angeletti, Fulvio Basolo, Generoso Bevilacqua
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (1): 155–161.
Published: 01 January 1999
View article titled, Thrombospondins I and II Messenger RNA Expression in Lung Carcinoma: <subtitle>Relationship with p53 Alterations, Angiogenic Growth Factors, and Vascular Density</subtitle>
Open the PDF for Thrombospondins I and II Messenger RNA Expression in Lung Carcinoma: <subtitle>Relationship with p53 Alterations, Angiogenic Growth Factors, and Vascular Density</subtitle> in another window